Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Renee Risingsong
Observed name:
R Risingsong
Observed institutions:
Dartmouth College,
National Institutes of Health,
Johns Hopkins University,
Johns Hopkins Medicine,
National Institute of Diabetes and Digestive and Kidney Diseases,
Dartmouth Health
show all 6
OpenAlex ID:
A5031590940
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
2005
·
Albena T. Dinkova-Kostova
, Karen T. Liby
, et al.
·
Proceedings of the National Academy of Sciences
·
569
The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling
2005
·
Karen Liby
, Thomas Hock
, et al.
·
Cancer Research
·
286
PDF
A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
1999
·
N Suh
, Y Wang
, et al.
·
PubMed
·
230
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
2011
·
Arie Neymotin
, Noel Y. Calingasan
, et al.
·
Free Radical Biology and Medicine
·
210
Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
2009
·
Lichuan Yang
, Noel Y. Calingasan
, et al.
·
PLoS ONE
·
172
PDF
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
2003
·
Andrew E Place
, Nanjoo Suh
, et al.
·
PubMed
·
147
The Synthetic Triterpenoids CDDO-Methyl Ester and CDDO-Ethyl Amide Prevent Lung Cancer Induced by Vinyl Carbamate in A/J Mice
2007
·
Karen Liby
, Darlene B. Royce
, et al.
·
Cancer Research
·
141
The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells
2006
·
Karen Liby
, Nga Voong
, et al.
·
Clinical Cancer Research
·
118
PDF
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
2010
·
Karen T. Liby
, Darlene B. Royce
, et al.
·
Cancer Prevention Research
·
90
PDF
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
2003
·
Nanjoo Suh
, Anita B Roberts
, et al.
·
PubMed
·
90
The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice
2014
·
Ciric To
, Eun-Hee Kim
, et al.
·
Cancer Prevention Research
·
85
Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
2008
·
Karen Liby
, Renee Risingsong
, et al.
·
Clinical Cancer Research
·
77
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.
2002
·
Nanjoo Suh
, William W Lamph
, et al.
·
PubMed
·
65
Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
2015
·
Ciric To
, Carol S. Ringelberg
, et al.
·
Carcinogenesis
·
64
Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities
2007
·
Karen Liby
, Tadashi Honda
, et al.
·
Molecular Cancer Therapeutics
·
60
The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer
2006
·
Karen Liby
, Mara Rendi
, et al.
·
Clinical Cancer Research
·
60
The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor β-Dependent Apoptosis in Breast Cancer
2004
·
Mara H. Rendi
, Nanjoo Suh
, et al.
·
Cancer Research
·
60
CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
2011
·
Eun-Hee Kim
, Chuxia Deng
, et al.
·
Cancer Prevention Research
·
57
Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
2009
·
Karen Liby
, Renee Risingsong
, et al.
·
Cancer Prevention Research
·
57
A Novel Acetylenic Tricyclic bis-(Cyano Enone) Potently Induces Phase 2 Cytoprotective Pathways and Blocks Liver Carcinogenesis Induced by Aflatoxin
2008
·
Karen Liby
, Mark M. Yore
, et al.
·
Cancer Research
·
52
PDF
Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A
2006
·
Tadashi Honda
, Karen T. Liby
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
48
The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
2012
·
Kim Tran
, Renee Risingsong
, et al.
·
Carcinogenesis
·
47
The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor–Negative Mammary Carcinogenesis in Polyoma Middle T Mice
2012
·
Kim Tran
, Renee Risingsong
, et al.
·
Cancer Prevention Research
·
46
A New Rexinoid, NRX194204, Prevents Carcinogenesis in Both the Lung and Mammary Gland
2007
·
Karen Liby
, Darlene B. Royce
, et al.
·
Clinical Cancer Research
·
39
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis
2008
·
Karen Liby
, Candice C. Black
, et al.
·
Molecular Cancer Therapeutics
·
33
Show more works
View as search
Works count:
52
Citation count:
2,968
H-index:
26
I10-index:
27
Year
Topic
Type
